CV Sciences (CVSI) Accumulated Expenses (2013 - 2026)
CV Sciences (CVSI) reported Accumulated Expenses of $2.6 million for Q1 2026, up 91.81% on a YoY basis from $1.4 million in Q1 2025, and up 8.17% sequentially from $2.4 million in Q4 2025.
CV Sciences (CVSI) Accumulated Expenses (2013 - 2026) Analysis & Trends
CV Sciences (CVSI) has 14 years of Accumulated Expenses data on file, last reported at $2.6 million in Q1 2026.
- For the quarter ending Q1 2026, Accumulated Expenses rose 91.81% year-over-year to $2.6 million; the trailing twelve-month figure through Mar 2026 stood at $2.6 million (up 91.81% YoY), and the FY2025 full-year result was $2.4 million, up 368.77% from the prior year.
- Accumulated Expenses improved to $2.6 million in Q1 2026, from $2.4 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $10.3 million in Q1 2022 to a low of $500000.0 in Q1 2023.
- A 5-year average of $3.8 million and a median of $2.9 million in 2024 frame the typical range for Accumulated Expenses.
- Across the five-year window, Accumulated Expenses slumped 95.13% in 2023 and soared 549.6% in 2024, its largest moves.
- Tracing CVSI's Accumulated Expenses over 5 years: stood at $6.7 million in 2022, then tumbled by 92.21% to $522000.0 in 2023, then changed by 0.0% to $522000.0 in 2024, then surged by 368.77% to $2.4 million in 2025, then climbed by 8.17% to $2.6 million in 2026.
- Business Quant data shows CVSI's Accumulated Expenses at $2.6 million in Q1 2026, $2.4 million in Q4 2025, and $1.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | CV Sciences | 3.74 Mn | 3.43 Mn | 1.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.65 Mn |
| Dec 31, 2025 | 2.45 Mn |
| Sep 30, 2025 | 1.37 Mn |
| Mar 31, 2025 | 1.38 Mn |
| Dec 31, 2024 | 522,000.00 |
| Sep 30, 2024 | 3.42 Mn |
| Jun 30, 2024 | 522,000.00 |
| Mar 31, 2024 | 3.25 Mn |
| Dec 31, 2023 | 522,000.00 |
| Sep 30, 2023 | 3.31 Mn |
| Jun 30, 2023 | 3.54 Mn |
| Mar 31, 2023 | 500,000.00 |
| Dec 31, 2022 | 6.70 Mn |
| Sep 30, 2022 | 9.72 Mn |
| Jun 30, 2022 | 9.93 Mn |
| Mar 31, 2022 | 10.28 Mn |
| Dec 31, 2021 | 10.92 Mn |
| Sep 30, 2021 | 10.80 Mn |
| Jun 30, 2021 | 10.23 Mn |
| Mar 31, 2021 | 10.24 Mn |